SUMMARY The effects of pentagastrin and the putative gastrin antagonist proglumide on interdigestive motility of the upper small bowel were studied in a randomised double blind study in 10 healthy human volunteers. Intraluminal pressures were recorded manometrically in the duodenum and jejunum for five hours. Sixty minutes after starting a pentagastrin infusion (0.15 ,ug/kg/h) either placebo or proglumide was infused intravenously. Pentagastrin converted the normal interdigestive motility to irregular motor activity, while proglumide restored the periodic fasted pattern. We conclude that gastrin is a likely candidate involved in the conversion of the fasted to the fed motility pattern in the human upper gut.
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In the fasted state, motility of the stomach and small intestine of man is characterised by periodic activity of the interdigestive migrating motor complex (MMC). [1] [2] [3] [4] Intraluminal pressures were measured manometrically by a triple lumen polyvinyl tube. The inside diameter of the three catheters was 0*8 mm each. The distal side openings of the three catheters were 20 cm apart. Beyond the side openings the catheters were occluded by a stainless steel plug. At their proximal ends the catheters were connected to pressure transducers. Pressure events were recorded via a bridge amplifier (Hellige TF 19) on a direct writing polygraph (Hellige P 31). The pressure transducers and the catheters were continuously perfused by a low compliance pneumohydraulic pump'5 at a rate of 9 ml H20 h-1.
Before each experiment the volunteers were fasted for 10 hours. The manometric tube was introduced through the mouth and positioned under radiographic control with its side openings into the duodenum and jejunum. The initial basal registration was continued, until the first activity front of the MMC had passed the duodenum. Then the volunteers received pentagastrin 0.15 ,ug/kg bodyweight/h by intravenous infusion for five hours. Sixty minutes after starting the pentagastrin infusion, in addition, either proglumide or the same volume of placebo solution (normal saline) was infused for four hours in a double blind fashion. The dose of proglumide was 400 mg as an initial 5 ml bolus followed by an infusion of 500 mg/h.
The order of the experiments (pentagastrin + proglumide or pentagastrin + placebo) was randomised. After the start of the additional infusion (proglumide or placebo), the pressure recordings were continued for four hours. The control experiment with either placebo or proglumide followed within one week. Serum proglumide concentrations were determined by gas chromatography. '6 We evaluated the number of activity fronts of the MMC in the duodenum and jejunum. Differences between the proglumide and placebo experiments were tested for significance by Student's t test for paired data.
Results
The results are given in Figures 1 and 2 . Pentagastrin 015 ,ug/kg bodyweight/h interrupted the normal interdigestive motility pattern of the upper intestine (Fig. 1) . During pentagastrin infusion the number of activity fronts in the duodenum and jejunum was reduced to 0 4±0 2 (x ± SEM/4 h). Irregular contractions prevailed (Fig. 3) .
Infusion of proglumide in addition to pentagastrin restored the normal periodic interdigestive motor activity (Fig. 2) brought about by pentagastrin administration is characterised by irregular motor activity. These findings lend support to the idea that the serum gastrin rise after feeding is involved in the conversion of the interdigestive to the digestive motility pattern in the upper gUt.6 7 9 Additional infusion of proglumide restores the interdigestive motility pattern which has a mean period between activity fronts of the MMC of approximately two hours. These findings support the hypothesis of proglumide being a gastrin-and CCK-receptor antagonist. 1"'3
Proglumide and pentagastrin have direct actions on the gastrointestinal smooth muscle cell" 17 18 in that they appear to act on CCK and gastrin receptors. In these observations pentagastrin and gastrin were shown to increase myoelectrical and motor activity of the stomach, while proglumide inhibited myoelectric and motor activity in the isolated stomach and ileum. ' 
